Surgical Outcomes of Lung Cancer in Patients with Combined Pulmonary Fibrosis and Emphysema

Annals of Surgical Oncology

Volumn 22, Issue , 2015, Pages 1371-1379

  Mimae, Takahiro ^a   Suzuki, Kenji ^b   Tsuboi, Masahiro ^c,d   Nagai, Kanji ^c   Ikeda, Norihiko ^e   Mitsudomi, Tetsuya ^f   Saji, Hisashi ^g   Okumura, Sakae ^h   Okumura, Meinoshin ⁱ   Yoshimura, Kenichi ^j,k   Okada, Morihito ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^d YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^e TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

^f KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h CANCER INSTITUTE HOSPITAL   (Japan)

ⁱ OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^k KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; BRONCHOPLEURAL FISTULA; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL FEATURE; COMBINED PULMONARY FIBROSIS AND EMPHYSEMA; COMPARATIVE STUDY; DISEASE EXACERBATION; EMPYEMA; FEMALE; GROUPS BY AGE; HOME OXYGEN THERAPY; HUMAN; INTERSTITIAL PNEUMONIA; JAPAN; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG LOBECTOMY; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLEOMORPHIC CARCINOMA; PNEUMONIA; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; SEX DIFFERENCE; SQUAMOUS CELL LUNG CARCINOMA; SURGICAL MORTALITY; VITAL CAPACITY; WEDGE RESECTION; COMPLICATION; FOLLOW UP; LUNG NEOPLASMS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; PULMONARY EMPHYSEMA; PULMONARY FIBROSIS; SURVIVAL RATE; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY;

AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY EMPHYSEMA; PULMONARY FIBROSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84952871705     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-015-4577-1     Document Type: Article

References (22)

1. Cottin V. The impact of emphysema in pulmonary fibrosis. Eur Respir Rev. 2013;22(128):153–157.
2. Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J. 2005;26(4):586–593.
3. Berndt A, Leme AS, Shapiro SD. Emerging genetics of COPD. EMBO Mol Med. 2012;4(11):1144-1155.
4. Congleton J, Muers MF. The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy. Respir Med. 1995;89(4):291–296.
5. Loganathan RS, Stover DE, Shi W, Venkatraman E. Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer. Chest. 2006;129(5):1305-1312.
6. Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009;34(2):380–386.
7. Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med. 2000;161(1):5–8.
8. Kitaguchi Y, Fujimoto K, Hanaoka M, Kawakami S, Honda T, Kubo K. Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology. 2010;15(2):265–271.
9. Usui K, Tanai C, Tanaka Y, Noda H, Ishihara T. The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer. Respirology. 2011;16(2):326–331.
10. Jankowich MD, Rounds SI. Combined pulmonary fibrosis and emphysema syndrome: a review. Chest. 2012;141(1):222–231.
11. Girard N, Marchand-Adam S, Naccache JM, et al. Lung cancer in combined pulmonary fibrosis and emphysema: a series of 47 Western patients. J Thorac Oncol. 2014;9(8):1162–1170.
12. Kumagai S, Marumo S, Yamanashi K, et al. Prognostic significance of combined pulmonary fibrosis and emphysema in patients with resected non-small-cell lung cancer: a retrospective cohort study. Eur J Cardiothorac Surg. 2014;46(6):e113–e119.
13. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007;2(8):706–714.
14. Mimae T, Tsutani Y, Miyata Y, et al. Role of lymphatic invasion in the prognosis of patients with clinical node-negative and pathologic node-positive lung adenocarcinoma. J Thorac Cardiovasc Surg. 2014;147(6):1820–1826.
15. National Institute of Health. National Cancer Institute. Common terminology criteria for adverse events (CTCAE version 4). U.S. Department of Health and Human Services 2010. http://evs.nci.nih.gov/ftp1/CTCAE/About.html.
16. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48(3):452–458.
17. Cottin V, Cordier JF. Combined pulmonary fibrosis and emphysema: an experimental and clinically relevant phenotype. Am J Respir Crit Care Med. 2005;172(12):1605; author reply 1605–1606.
18. Inoue M, Okumura M, Sawabata N, et al. Clinicopathological characteristics and surgical results of lung cancer patients aged up to 50 years: the Japanese Lung Cancer Registry Study 2004. Lung Cancer. 2013.
19. Kuwano H, Amano J, Yokomise H. Thoracic and cardiovascular surgery in Japan during 2010: annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2012;60(10):680–708.
20. Mimae T, Hagiyama M, Inoue T, et al. Increased ectodomain shedding of lung epithelial cell adhesion molecule 1 as a cause of increased alveolar cell apoptosis in emphysema. Thorax. 2014;69(3):223–231.
21. Collard HR, King TE, Jr., Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003;168(5):538–542.
22. Triantafillidou C, Manali E, Lyberopoulos P et al. The role of cardiopulmonary exercise test in IPF prognosis. Pulm Med. 2013;2013:514817. doi:10.1155/2013/514817.